Matricelf Ltd (TA:MTLF) — Market Cap & Net Worth
Market Cap & Net Worth: Matricelf Ltd (MTLF)
Matricelf Ltd (TA:MTLF) has a market capitalization of $21.04 Million (ILA7.85 Billion) as of May 4, 2026. Listed on the TA stock exchange, this Israel-based company holds position #24882 globally and #364 in its home market, demonstrating a -15.36% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Matricelf Ltd's stock price ILA268.40 by its total outstanding shares 29244761 (29.24 Million). Analyse MTLF cash flow metrics to see how efficiently the company converts income to cash.
Matricelf Ltd Market Cap History: 2021 to 2026
Matricelf Ltd's market capitalization history from 2021 to 2026. Data shows change from $67.46 Million to $22.09 Million (-13.00% CAGR).
Matricelf Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Matricelf Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MTLF by Market Capitalization
Companies near Matricelf Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to Matricelf Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Matricelf Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Matricelf Ltd's market cap moved from $67.46 Million to $ 22.09 Million, with a yearly change of -13.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA22.09 Million | -48.87% |
| 2025 | ILA43.19 Million | +50.27% |
| 2024 | ILA28.74 Million | -11.51% |
| 2023 | ILA32.48 Million | -7.15% |
| 2022 | ILA34.98 Million | -48.14% |
| 2021 | ILA67.46 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Matricelf Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $21.04 Million USD |
| MoneyControl | $21.04 Million USD |
| MarketWatch | $21.04 Million USD |
| marketcap.company | $21.04 Million USD |
| Reuters | $21.04 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Matricelf Ltd
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 20… Read more